In the fight against PKD, your contribution is important

Living with autosomal dominant polycystic kidney disease (ADPKD) can be painful and overwhelming. If you have ADPKD, you may want to learn more about the REPRISE clinical research study.

See if you may be able to participate

The REPRISE study is investigating whether tolvaptan can reduce cyst growth and delay kidney failure in adults with ADPKD.

You may be able to join the study if you:

  • Are between the ages of 18 to 55 years old; patients aged 56 to 65 may be able to participate in some circumstances
  • Are diagnosed with ADPKD

To learn more or to see if you may be eligible for this study, visit